98%
921
2 minutes
20
The ARCN1 gene encodes the delta subunit of the coatomer protein complex I (COPI), which is essential for mediating protein transport from the Golgi complex to the endoplasmic reticulum. Variants in ARCN1 are associated with clinical features such as microcephaly, microretrognathia, intrauterine growth restriction, short rhizomelic stature, and developmental delays. We present a case of a patient exhibiting intrauterine growth restriction, preterm birth, microcephaly, micrognathia, and central precocious puberty. Whole-exome sequencing identified a novel splice-site variant, NM_001655.5: c.1241 + 1G > A, in the ARCN1 gene. To our knowledge, this is the first documented case of ARCN1-related syndrome associated with central precocious puberty, contributing to the understanding of the disease phenotype.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11674155 | PMC |
http://dx.doi.org/10.1186/s12887-024-05329-2 | DOI Listing |
Ann Pediatr Endocrinol Metab
August 2025
Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Purpose: Gonadotropin-releasing hormone agonists are the standard treatment for central precocious puberty (CPP). These agonists include leuprolide acetate and triptorelin pamoate, but research data for the relative effectiveness of these 2 treatments in overweight and obese girls experiencing CPP are lacking. In this study, we compared the effectiveness of these 2 therapeutics, leuprolide acetate and triptorelin pamoate, in the treatment of overweight and obese girls affected by CPP.
View Article and Find Full Text PDFAnn Pediatr Endocrinol Metab
August 2025
Department of Pediatrics, Inje University Sanggye Paik Hospital, Inje University School of Medicine, Seoul, Korea.
The fission yeast phosphate acquisition (PHO) regulon is repressed under phosphate-replete conditions by upstream lncRNA-mediated transcriptional interference. Inositol-1-pyrophosphates control phosphate homeostasis via their action as agonists of precocious PHO lncRNA 3'-processing/termination. Inositol pyrophosphatase-inactivating mutations that increase inositol-1-pyrophosphates elicit derepression of the PHO genes and a severe growth defect in YES medium.
View Article and Find Full Text PDFJ Pediatr Nurs
September 2025
Department of Pediatrics, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan; Department of Nursing, Chang Gung University of Science and Technology, Taoyuan, Taiwan. Electronic address:
Purpose: Parents of children newly diagnosed with central precocious puberty often face emotional stress and time-sensitive treatment decisions, highlighting the importance of family-centered care. This cross-sectional study examined the relationship between parental health literacy and medical decision conflict.
Methods: A total of 65 parents of children newly diagnosed with central precocious puberty were recruited.
Toxicology
August 2025
Department of Food Nutrition and Safety, Dalian Medical University, No. 9 W. Lushun South Road, Dalian 116044, China. Electronic address:
Di(2-ethylhexyl) phthalate (DEHP), the most prevalent plasticizer worldwide, can enter the human body via various exposure pathways, including ingestion, inhalation, skin contact, and medical applications. It has been observed to exhibit characteristic patterns of accumulation in the female reproductive system. Research has demonstrated that DEHP poses a threat to reproductive health in females across various life stages.
View Article and Find Full Text PDF